FAMOTIDINE TEVA 40 MG

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Kup teraz

Składnik aktywny:

FAMOTIDINE

Dostępny od:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Kod ATC:

A02BA03

Forma farmaceutyczna:

TABLETS

Skład:

FAMOTIDINE 40 MG

Droga podania:

PER OS

Typ recepty:

Required

Wyprodukowano przez:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Dziedzina terapeutyczna:

FAMOTIDINE

Wskazania:

Treatment of Duodenal Ulcer, Benign Gastric Ulcer, Pathological hypersecretory conditions such as Zollinger-ellison syndrome, Gastroesophageal reflux disease. Prevention of relapses of duodenal ulceration.

Data autoryzacji:

2014-12-11

Ulotka dla pacjenta

                                PATIENT LEAFLET IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) – 1986
THE MEDICINE IS DISPENSED WITH A DOCTOR'S
PRESCRIPTION ONLY
FAMOTIDINE TEVA 40 MG
TABLETS
THE ACTIVE INGREDIENT AND ITS QUANTITY:
Each tablet contains:
Famotidine 40 mg
For information regarding inactive ingredients and allergens,
see section 2 - “Important information about some ingredients
of the medicine” and section 6 - “Additional information”.
READ
THE
ENTIRE
LEAFLET
CAREFULLY
BEFORE
USING
THE
MEDICINE. This leaflet contains concise information about
the medicine. If you have additional questions, refer to the
doctor or the pharmacist.
This medicine has been prescribed for treatment of your
illness. Do not pass this medicine on to others. It may harm
them even if it seems to you that their medical condition is
similar.
This medicine is not intended for use in children under 12
years of age.
You
should
use
the
medicine
properly.
Consult
the
pharmacist if you need more information.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for treatment of conditions in which
reduced secretion of gastric juices is required, including
treatment of a gastric or duodenal ulcer, esophageal
inflammation caused by Gastroesophageal Reflux Disease
and Zollinger-Ellison syndrome.
THERAPEUTIC CLASS:
Inhibitors
of
gastric
acid
secretion
of
the
histamine
2
antagonists group.
2. BEFORE USING THE MEDICINE:
DO NOT USE THIS MEDICINE IF:
•
You are sensitive to the active ingredient famotidine or
to any of the other ingredients the medicine contains or
to other medicines of this group (cimetidine, ranitidine
or nizatidine).
•
You are breastfeeding.
SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE
BEFORE TREATMENT WITH FAMOTIDINE TEVA, TELL THE DOCTOR
IF:
•
You are pregnant or planning to become pregnant.
•
You have or have had in the past impaired liver function.
•
You have or have had in the past a kidney disease or
urinary system impairment.
•
You are sensitive to any food or medicine or to ingredients
such as 
                                
                                Przeczytaj cały dokument
                                
                            

Dokumenty w innych językach

Ulotka dla pacjenta Ulotka dla pacjenta arabski 11-08-2022
Ulotka dla pacjenta Ulotka dla pacjenta hebrajski 11-08-2022

Wyszukaj powiadomienia związane z tym produktem